Singapore, Sept. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations'. The following are the other relevant details related to the trial:
Therapeutic Area: Oncology (including Haematology-Oncology)
Trial Centre(s):
National Cancer Centre
National University Hospital
Tan Tock Seng Hospital
Trial Status: NA
Principal Investigator(s):
Dr Dr. Tan Jing Ying Tira
Dr Yong Wei Peng
Dr Dr. Valerie Heong
Published by HT Digital Content Services with permission from Health Daily Digest....